Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.
You may also be interested in...
“Devil Is In The Details” On Prop 65 Reform Benefits – AHPA
California Governor Jerry Brown proposes to tweak Proposition 65 to reduce the number of frivolous lawsuits against small businesses. More than 10% of Prop 65 litigation targets since 2008 have been supplement firms, says the American Herbal Products Association.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.